Keyphrases
1-methyl-D-tryptophan
30%
Antigen-presenting Cells
30%
Antigenic Peptide
10%
B16F10
10%
Cancer Immunotherapy
10%
Cell Cycle Arrest
10%
Clonal Expansion
10%
CTL Activity
10%
Dendritic Cells
10%
Functional Tolerance
10%
Human Tumors
10%
Immunization
10%
Indoleamine 2,3-dioxygenase 1 (IDO1)
100%
Indoleamine 2,3-dioxygenase Inhibitor
10%
Inhibitor Drug
10%
Knock-in Mouse Model
10%
Malignancy
100%
Malignant Melanoma
10%
New Therapeutic Strategies
10%
Pathologic
10%
Prophylactic Vaccination
10%
Protective Immune Response
10%
T Cell Response
20%
T Cells
10%
Therapeutic Immunization
10%
Therapeutic Intervention
10%
Tolerogenic
10%
Transgenic
10%
Tryptophan Catabolism
10%
Tumor
20%
Tumor Antigen
20%
Tumor Cells
10%
Tumor Model
10%
Tumor-draining Lymph Nodes
20%
Unresponsiveness
10%
Vaccination
10%
Immunology and Microbiology
Antigen-Presenting Cell
27%
Cell Cycle Arrest
9%
Cell Cycle Checkpoint
9%
Dendritic Cell
9%
Immune Response
9%
Immunotherapy
9%
Indoleamine 2,3-dioxygenase
100%
Knockout Mouse
9%
Lymph Node
18%
Peptides
9%
T Cell
27%
Transgenics
9%
Tryptophan
36%
Tumor Antigen
18%
Tumor Cell
9%